Your session is about to expire
← Back to Search
Financial Incentives + Communication Training for HPV Vaccine Uptake
N/A
Recruiting
Led By Justin G Trogdon, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 13 months to 24 months
Awards & highlights
Study Summary
This trial will explore how financial incentives + communication training can increase HPV vaccine uptake in clinics.
Who is the study for?
This trial is for pediatric or family medicine clinics in North Carolina with less than a 72% HPV vaccine initiation rate and at least 50 patients aged 9-12. Clinics must have at least two providers offering the HPV vaccine and no recent financial incentives or communication training aimed at increasing vaccination rates.Check my eligibility
What is being tested?
The study is testing if giving clinics financial rewards, along with communication training, increases the number of kids getting the HPV vaccine. Some clinics will just get training, while others will also receive money based on their performance plus monthly progress reports.See study design
What are the potential side effects?
Since this trial involves non-medical interventions (financial incentives and communication training), there are no direct medical side effects to participants. However, it's important to monitor for any unintended consequences that these incentives might have on clinic practices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from 13 months to 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 13 months to 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
HPV vaccination (≥1 dose), 9-12 year olds
HPV vaccination (≥2 doses), 9-12 year olds
Trial Design
2Treatment groups
Experimental Treatment
Group I: HPV vaccine communication training.Experimental Treatment1 Intervention
Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination.
Group II: HPV vaccine communication training and clinic-level financial incentive programExperimental Treatment2 Interventions
Staff in clinics randomized to this arm will receive the Announcement Approach Training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
Find a Location
Who is running the clinical trial?
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
351 Previous Clinical Trials
88,299 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,666 Previous Clinical Trials
40,925,971 Total Patients Enrolled
Justin G Trogdon, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My clinic does not offer HPV vaccines to children aged 9-12.My clinic received HPV vaccine communication training recently.My clinic treats fewer than 49 patients aged 9-12.My child is between 9 and 12 years old.My clinic has seen 50 or more patients aged 9-12 last year.My clinic offers the HPV vaccine from 2 or more providers.My clinic's HPV vaccine start rate was below 72% last year.My child is between 9 and 12 years old.
Research Study Groups:
This trial has the following groups:- Group 1: HPV vaccine communication training and clinic-level financial incentive program
- Group 2: HPV vaccine communication training.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are geriatric participants included in the scope of this research?
"The study is in need of participants between the ages 9 and 12."
Answered by AI
Does my profile meet the requirements of participating in this clinical trial?
"To qualify for enrolment, participants need to be between 9 and 12 years old with a HPV diagnosis. Currently, the study is aiming to attract 34 subjects."
Answered by AI
Is this research endeavor looking for new participants?
"Data hosted on clinicaltrials.gov conveys that this medical study, which was initially launched on February 28th 2023, is actively searching for patients to enroll in the trial. The entry has been amended most recently on February 15th 2023."
Answered by AI
How many individuals have taken part in this clinical investigation?
"Indeed, information on clinicaltrials.gov verifies that enrollment for this medical research is currently open. It was first introduced to the public on February 28th 2023 and has received alterations as recent as February 15th 2023. The number of participants sought is 34 across 1 centre."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger